Package 0378-4276-77

{"route": ["ORAL"], "spl_id": "eec31f7b-9bdf-4a19-84de-14a5dc5831e6", "openfda": {"upc": ["0303784276938", "0303784275931"], "unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["56bf715d-8280-4557-9f98-9693932199e5"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4276-77)", "package_ndc": "0378-4276-77", "marketing_start_date": "20100524"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4276-93)", "package_ndc": "0378-4276-93", "marketing_start_date": "20100524"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "0378-4276_eec31f7b-9bdf-4a19-84de-14a5dc5831e6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "0378-4276", "generic_name": "valacyclovir", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA078518", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20271231"}